샘플 요청 목록

 카트 문의
시장보고서
상품코드
1533667

세계의 항말라리아 약물 시장

Anti-Malarial Medicines
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 288 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

항말라리아 약물 시장은 2030년까지 12억 달러에 이를 것으로 예상됩니다.

2023년에 9억 6,020만 달러로 추정된 항말라리아 약물 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 2.7%로 성장하고, 2030년에는 12억 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 항엽산 화합물은 복합 연간 성장률(CAGR) 2.9%로 성장을 지속하여, 분석 기간 종료 시에는 4억 6,280만 달러에 달할 것으로 예상됩니다. 아릴아미노알코올 화합물 분절의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 2.0%로 추정됩니다.

미국 시장은 2억 6,160만 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 5.3%로 성장할 것으로 예측됩니다.

미국의 항말라리아 약물 시장은 2023년 2억 6,160만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023-2030년 복합 연간 성장률(CAGR)을 5.3%로 2030년까지 2억 3,170만 달러 규모에 이를 것으로 예측되고 있습니다. 기타 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 0.7%와 2.0%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 1.3%로 성장할 것으로 예측됩니다.

세계의 항말라리아 약물 시장 : 주요 동향 및 촉진요인 요약

말라리아의 치료와 제압은 효과적인 항말라리아 약물에 크게 의존합니다. 이 약물은 감염자를 치유 할뿐만 아니라 특히 감염률이 낮은 지역에서이 질병의 감염을 줄이기 위해 매우 중요합니다. 아르테미시닌 병용요법(ACT)과 같은 항말라리아 치료는 기생충 증후성의 무성기와 보다 저항성이 강한 성기(배우 세포)를 모두 표적으로 함으로써 말라리아 관리에 도움이 됩니다. 네. 특히 프리마킨은 비바키 원충과 오바레 원충에 효과적이며 휴면 중 간 단계를 표적으로 하여 재발을 막을 수 있었습니다. 그러나 프리마킨의 사용은 말라리아 유행 지역에서 일반적인 G6PD 결핍증을 가진 사람에게 심각한 부작용을 일으킬 수 있기 때문에 우려됩니다. 특히 G6PD 결핍증의 종합적인 스크리닝이 없는 경우, 부작용을 최소화하면서 효과적인 치료의 균형을 잡는다는 과제가 남습니다.

항말라리아 약물의 유통과 효능은 말라리아 제압의 큰 장벽이되는 약물 내성을 포함한 많은 요인에 의해 영향을받습니다. 클로로킨이나 설파독신-피리메타민과 같은 옛 약물에 대한 내성은 ACT의 사용 증가로 이어졌습니다. 그러나 이러한 새로운 치료제에 대한 내성이 나타나면 말라리아 대책의 최근 결과를 손상시킬 수 있습니다. 역학적 연구에 따르면, 감염률이 높은 지역에서는 감염자와 면역 수준이 혼재하고 있기 때문에 내성균의 영향을 완화할 수 있지만, 감염률이 낮은 지역에서는 감염자가 적고 면역력이 낮기 때문에 내성균의 만연과 정착이 빨라질 가능성이 있습니다. 따라서 약물의 효능을 유지하기 위해서는 지속적인 모니터링과 내성 패턴을 기반으로 한 약물 정책의 적응이 매우 중요합니다. 또한, 약물의 작용과 전달을 개선하는 제약 기술의 혁신은 내성 박테리아에 앞서 필수적입니다.

항말라리아 약물 시장의 성장은 보다 효과적이고 안전한 제형으로 이어지는 제약 기술의 발전과 신약의 지속적인 개발을 필요로 하는 기존 약물에 대한 내성이 증가하는 등 여러 요인에 의해 초래됩니다. 정부 및 비정부 조직은 약물의 유통을 촉진하고 말라리아 대책 프로그램을 지원하는 공중 보건 이니셔티브를 추진하는데 중요한 역할을 합니다. 약물의 대량 투여 및 예방 치료를 포함한 공중 보건 정책 및 프로그램은 말라리아의 부담을 줄이는 데 도움이 됩니다. 또한, 유행 지역에서 건강 관리의 인프라를 확장하여 약물의 가용성과 치료 범위를 확대 할 수 있습니다. 말라리아 지역을 확대할 수 있는 기후 패턴의 변화는 또한 새로운 지역에서 효과적인 항말라리아 약물 수요를 증가시킵니다. 마지막으로 말라리아의 예방과 치료 옵션에 대한 소비자의 인식과 교육의 향상은 이러한 필수 의약품에 대한 수요를 촉진하고 있습니다.

조사 대상 기업 예(주목의 48사)

  • Alvizia Healthcare
  • Dewcare Concept Pvt. Ltd
  • Eisai Co., Ltd.
  • GSK plc
  • Ipca Laboratories Ltd
  • Lincoln Pharmaceuticals Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer, Inc.
  • Shanghai Fosun Pharmaceutical(Group) Co., Ltd.
  • Strides Pharma Science Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Zydus Lifesciences Limited;

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.08.20

Global Anti-Malarial Medicines Market to Reach US$1.2 Billion by 2030

The global market for Anti-Malarial Medicines estimated at US$960.2 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2023-2030. Antifolate Compounds, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$462.8 Million by the end of the analysis period. Growth in the Aryl Aminoalcohol Compounds segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$261.6 Million While China is Forecast to Grow at 5.3% CAGR

The Anti-Malarial Medicines market in the U.S. is estimated at US$261.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$231.7 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 2.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global Anti-Malarial Medicines Market - Key Trends and Drivers Summarized

The treatment and control of malaria heavily depend on effective anti-malarial drugs. These medications are crucial not only for curing the infected but also for reducing the transmission of the disease, especially in regions with low transmission. Anti-malarial treatments such as artemisinin combination therapies (ACTs) have been instrumental in managing falciparum malaria by targeting both the symptomatic asexual stages and the more resistant sexual stages (gametocytes) of the parasite. Primaquine, in particular, has been effective against Plasmodium vivax and ovale by targeting the dormant liver stages and preventing relapses. However, the use of primaquine raises concerns due to its potential severe side effects in people with G6PD deficiency, a common condition in malaria-endemic areas. The challenge remains to balance effective treatment while minimizing adverse effects, especially without comprehensive screening for G6PD deficiency.

The distribution and efficacy of anti-malarial drugs are affected by numerous factors, including drug resistance which has become a significant barrier in malaria control. Resistance to older drugs like chloroquine and sulfadoxine-pyrimethamine has led to the increased use of ACTs. However, the emergence of resistance to these newer treatments could undermine recent gains in malaria control. Epidemiological studies suggest that while high transmission regions can buffer the impact of resistance due to a mix of infected individuals and immunity levels, low transmission areas may see a quicker spread and establishment of resistant strains due to fewer infections and lower immunity. Therefore, ongoing monitoring and adapting drug policies based on resistance patterns are crucial for maintaining drug efficacy. Furthermore, innovations in pharmaceutical technology that improve drug action and delivery are vital for staying ahead of resistance.

The growth in the anti-malarial drug market is driven by several factors including advancements in pharmaceutical technologies which lead to more effective and safer formulations, and the rising resistance to existing medications which necessitates continuous development of new drugs. Government and non-governmental organizations play crucial roles in enhancing drug distribution and promoting public health initiatives that support malaria control programs. Public health policies and programs that include mass drug administration and preventive treatments help reduce the burden of malaria. Additionally, the expansion of healthcare infrastructure in endemic regions ensures better drug availability and treatment coverage. Changes in climate patterns that potentially expand malaria zones also increase the demand for effective anti-malarial drugs in new regions. Lastly, increased consumer awareness and education about malaria prevention and treatment options drive the demand for these essential medications.

Select Competitors (Total 48 Featured) -

  • Alvizia Healthcare
  • Dewcare Concept Pvt. Ltd
  • Eisai Co., Ltd.
  • GSK plc
  • Ipca Laboratories Ltd
  • Lincoln Pharmaceuticals Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer, Inc.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Strides Pharma Science Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Zydus Lifesciences Limited;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Anti-Malarial Medicines - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Global Malaria Incidence Drives Urgency for Effective Treatments
    • WHO Initiatives and Funding Increases Access to Anti-Malarial Medicines
    • Resistance to Existing Anti-Malarial Drugs Spurs Innovation in Treatment Options
    • Development of Combination Therapies Enhances Treatment Efficacy and Market Adoption
    • Climate Change and Expanding Malaria Zones Increase Demand for Medications
    • Growing Travel to Endemic Regions Accelerates Need for Prophylactic Medicines
    • Generic Medicine Production Expands Addressable Market Opportunity
    • Government Subsidies and Policies to Reduce Treatment Costs Sustain Market Growth
    • Rise in Pediatric Malaria and Specialized Treatment Demands Drive Market Segmentation
    • Emergence of Home-Based Rapid Testing Kits Enhances Early Treatment Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Anti-Malarial Medicines Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Anti-Malarial Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Anti-Malarial Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antifolate Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antifolate Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antifolate Compounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Aryl Aminoalcohol Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Aryl Aminoalcohol Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Aryl Aminoalcohol Compounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Artemisinin Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Artemisinin Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Artemisinin Compounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • JAPAN
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • CHINA
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • EUROPE
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Anti-Malarial Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Anti-Malarial Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • FRANCE
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • GERMANY
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Anti-Malarial Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Anti-Malarial Medicines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • INDIA
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Anti-Malarial Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Anti-Malarial Medicines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Anti-Malarial Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Anti-Malarial Medicines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030
  • AFRICA
    • Anti-Malarial Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Anti-Malarial Medicines by Drug Class - Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Anti-Malarial Medicines by Drug Class - Percentage Breakdown of Value Sales for Antifolate Compounds, Aryl Aminoalcohol Compounds, Artemisinin Compounds and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Anti-Malarial Medicines by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Anti-Malarial Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제